NOVARNICA Trademark

Trademark Overview

On Friday, November 28, 2025, a trademark application was filed for NOVARNICA with the United States Patent and Trademark Office. The USPTO has given the NOVARNICA trademark a serial number of 99520254. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, June 15, 2026. This trademark is owned by JETAFAM INC.. The NOVARNICA trademark is filed in the Pharmaceutical Products category with the following description:

Medicated foot creams; Pain relief medication; Preparation for the relief of pain

General Information

Serial Number99520254
Word MarkNOVARNICA
Filing DateFriday, November 28, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, June 15, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedicated foot creams; Pain relief medication; Preparation for the relief of pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJETAFAM INC.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressBeloeil, QC J3G 0X6
CA

Trademark Events

Event DateEvent Description
Friday, November 28, 2025NEW APPLICATION ENTERED
Friday, November 28, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 28, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, February 17, 2026ASSIGNED TO EXAMINER
Tuesday, February 17, 2026NON-FINAL ACTION WRITTEN
Tuesday, February 17, 2026NON-FINAL ACTION E-MAILED
Tuesday, February 17, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, March 8, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, March 8, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 9, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 9, 2026FINAL REFUSAL WRITTEN
Monday, March 9, 2026FINAL REFUSAL E-MAILED
Monday, March 9, 2026NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, June 7, 2026TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sunday, June 7, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 8, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 8, 2026ACTION CONTINUING A FINAL - COMPLETED
Monday, June 8, 2026CONTINUATION OF FINAL REFUSAL E-MAILED
Monday, June 8, 2026NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Monday, June 15, 2026TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, June 15, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 15, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 15, 2026NON-FINAL ACTION WRITTEN
Monday, June 15, 2026NON-FINAL ACTION E-MAILED
Monday, June 15, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

novarnica relief pain preparation medication foot medicated creams